Literature DB >> 2121839

Pulmonary clearance and phagocytic cell response in a murine model of Branhamella catarrhalis infection.

A Verghese1, E Berro, J Berro, B W Franzus.   

Abstract

C5-sufficient Swiss-Webster mice (C5+) and C5-deficient DBA/2J mice (C5-) when challenged endotracheally with 2 x 10(7) cfu of Branhamella catarrhalis rapidly clear the lungs of viable bacteria in 48 h. This rapid clearance correlates with a striking influx of polymorphonuclear neutrophils that is of equal magnitude in both C5+ and C5- animals. Supernatant from Todd-Hewitt broth culture of B. catarrhalis exhibits in vivo chemotactic activity in the murine lung and in vitro chemotactic activity in Boyden chambers. The ability of B. catarrhalis to recruit granulocytes, independent of complement, may suggest a role for this organism in promoting protease-mediated lung destruction.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2121839     DOI: 10.1093/infdis/162.5.1189

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  7 in total

Review 1.  [Moraxella catarrhalis: virulence and resistance mechanisms].

Authors:  W Cullmann
Journal:  Med Klin (Munich)       Date:  1997-03-15

Review 2.  Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review.

Authors:  S Sethi; T F Murphy
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

Review 3.  Moraxella catarrhalis: from emerging to established pathogen.

Authors:  Cees M Verduin; Cees Hol; André Fleer; Hans van Dijk; Alex van Belkum
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

4.  Evaluation of purified UspA from Moraxella catarrhalis as a vaccine in a murine model after active immunization.

Authors:  D Chen; J C McMichael; K R VanDerMeid; D Hahn; T Mininni; J Cowell; J Eldridge
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

5.  Intranasal vaccination with recombinant outer membrane protein CD and adamantylamide dipeptide as the mucosal adjuvant enhances pulmonary clearance of Moraxella catarrhalis in an experimental murine model.

Authors:  Pablo D Becker; Gustavo M Bertot; David Souss; Thomas Ebensen; Carlos A Guzmán; Saúl Grinstein
Journal:  Infect Immun       Date:  2006-11-13       Impact factor: 3.441

Review 6.  Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune response.

Authors:  T F Murphy
Journal:  Microbiol Rev       Date:  1996-06

7.  Characterization of proteins Msp22 and Msp75 as vaccine antigens of Moraxella catarrhalis.

Authors:  Elizabeth A Ruckdeschel; Aimee L Brauer; Antoinette Johnson; Timothy F Murphy
Journal:  Vaccine       Date:  2009-09-26       Impact factor: 3.641

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.